Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Ghoreishi, Zohreh ^a   Esfahani, Ali ^b   Djazayeri, Abolghasem ^a   Djalali, Mahmoud ^a   Golestan, Banafsheh ^a   Ayromlou, Hormoz ^c   Hashemzade, Shahriar ^d   Asghari Jafarabadi, Mohammad ^e   Montazeri, Vahid ^d   Keshavarz, Seyed A ^a   Darabi, Masoud ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Omega 3 fatty acids; Paclitaxel; Peripheral neuropathy

Indexed keywords

EBETAXEL; MOR DHA MINI I Q; OMEGA 3 FATTY ACID; PACLITAXEL; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MOTOR NERVE CONDUCTION; MULTIPLE CYCLE TREATMENT; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROPROTECTION; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REDUCED TOTAL NEUROPATHY SCORE; SCORING SYSTEM; SENSORY NERVE CONDUCTION; SUPPLEMENTATION;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MIDDLE AGED; NEURAL CONDUCTION; NEUROPROTECTIVE AGENTS; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; TREATMENT OUTCOME;

EID: 84864946546     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-355     Document Type: Article

References (25)

1. Hagiwara H, Sunada Y. Mechanism of taxane neurotoxicity. Breast Cancer 2004, 11(1):82-85. 10.1007/BF02968008, 14718798.
2. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 1994, 35(3):304-311. 10.1002/ana.410350310, 7907208.
3. Kuroi K, Shimozuma K. Neurotoxicity of taxanes: symptoms and quality of life assessment. Breast Cancer 2004, 11(1):92-99. 10.1007/BF02968010, 14718800.
4. Stillman M, Cata JP. Management of chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 2006, 10(4):279-287. 10.1007/s11916-006-0033-z, 16834943.
5. Shapiro H. Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system?. Prostaglandins Leukot Essent Fatty Acids 2003, 68(3):219-224. 10.1016/S0952-3278(02)00273-9, 12591006.
6. Mazza M, Pomponi M, Janiri L, Bria P, Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. In., vol. 31. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(1):12-26. Epub 2006 Aug 28, 10.1016/j.pnpbp.2006.07.010, 16938373.
7. Coste TC, Gerbi A, Vague P, Pieroni G, Raccah D. Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy. Am Diabetes Assoc 2003, 52:2578.
8. Cavaletti G, Bogliun G, Marzorati L, Zincone A, Piatti M, Colombo N, Parma G, Lissoni A, Fei F, Cundari S, et al. Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale. Neurology 2003, 61(9):1297-1300. 10.1212/01.WNL.0000092015.03923.19, 14610145.
9. Ocean AJ, Vahdat LT. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer 2004, 12(9):619-625.
10. Kimura J. Electrodiagnosis in diseases of nerve and muscle, principles and practice 2001, Oxford University Press , 3.
11. Noori M, Darabi M, Rahimipour A, Rahbani M, Abadi NA, Darabi M, Ghatrehsamani K. Fatty acid composition of HDL phospholipids and coronary artery disease. J Clin Lipidol 2009, 3(1):39-44. 10.1016/j.jacl.2008.11.010, 21291787.
12. Pocock SJ. Clinical Trials: A Practical Approach 1983, John Wiley & Sons .
13. Okuda Y, Mizutani M, Ogawa M, Sone H, Asano M, Asakura Y, Isaka M, Suzuki S, Kawakami Y, Field JB. Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus. In., vol. 10 1996, 280-287. Elsevier .
14. Taxol Prescribing Information. Bristol Meyers Squibb Available at http://www.accessdata.fda.gov/scripts/cder/onctools/labels.cfm?GN=paclitaxel. Accessed April 13,2005, Taxol Prescribing Information. Bristol Meyers Squibb.
15. Head KA. Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Rev 2006, 11(4):294-329.
16. Gerbi A, Maixent JM, Ansaldi JL, Pierlovisi M, Coste T, Pelissier JF, Vague P, Raccah D. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats. Am Soc Nutrition 1999, 129:207.
17. Mielke S, Sparreboom A, Mross K. Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes. Eur J Cancer 2006, 42(1):24-30. 10.1016/j.ejca.2005.06.030, 16293411.
18. Argyriou AA, Polychronopoulos P, Koutras A, Iconomou G, Iconomou A, Kalofonos HP, Chroni E. Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?. Support Care Cancer 2005, 13(8):647-651. 10.1007/s00520-005-0776-9, 15711945.
19. Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C. Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 2007, 11(6):901-913. 10.1188/07.CJON.901-913, 18063548.
20. Lauretani F, Bandinelli S, Benedetta B, Cherubini A, Iorio AD, Ble A, Giacomini V, Corsi AM, Guralnik JM, Ferrucci L. Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons. In., vol. 14 2007, 801-808. Wiley Online Library .
21. Ward RE, Huang W, Hall JCE, Priestley JV, Michael-Titus AT. Effect of docosahexaenoic acid on axonal damage after spinal cord injury. In., vol. 14 2007,
22. Wolff AC, Donehower RC, Carducci MK, Carducci MA, Brahmer JR, Zabelina Y, Bradley MO, Anthony FH, Swindell CS, Witman PA, et al. Phase I study of docosahexaenoic acid-paclitaxel: a taxane-fatty acid conjugate with a unique pharmacology and toxicity profile. Clin Cancer Res 2003, 9(10 Pt 1):3589-3597.
23. Ocean AJ, Vahdat LT. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. In., vol. 12 2004, 619-625. Springer .
24. Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B. n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 2000, 275(2):721-724. 10.1074/jbc.275.2.721, 10625599.
25. Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for cardioprotection. Mayo Clinic 2008, 83:324-332.